(Q84072437)
Statements
Olmesartan, a novel angiotensin II type 1 receptor antagonist, reduces severity of atherosclerosis in apolipoprotein E deficient mice associated with reducing superoxide production (English)
K Shimada
T Murayama
M Yokode
T Kita
M Fujita